Abstract:Background: Islet cell transplantation can improve islet function, but the source is lack. Bone marrow mesenchymal stem cells (BMSCs) can be induced to differentiate into islet cells, and have strong tissue repair ability in diabetes foot, diabetic cardiomyopathy and diabetic neuropathy. Objective: To investigate BMSC survival and turnover and improvement in blood glucose and renal lesions in model rats of type 2 diabetes following BMSC transplantation. Design, time and setting: The cytology in vivo study was performed at the Department of Biochemistry and Molecular Biology, Shanxi Medical University from February to July 2008. Materials: Male Wistar rats were provided by Animal Experimental Center, Shanxi Medical University. Streptozotocin (Sigma, USA) was used for this study. Methods: BMSCs were isolated from rat (4-week old) bone marrow in vitro, adhered and purified. At the third passage, BrdU-labeled BMSCs were used for transplantation. A total of 60 rats were randomly assigned into 3 groups. Rats in the model control and cell transplantation groups were administered with standard mixed feed, supplemented with 0.1 volume fraction pork fat and high-fat yolk, for 2 months. Streptozotocin was intraperitoneally injected into rats. The type 2 diabetic models were affirmed when the blood glucose level at least 16.77 mmol/L and stabilized for three days. Rats in the normal group were treated with standard mixed feed for 2 months. An equal volume of citrate buffer solution was intraperitoneally injected into rats. Following successful model induction, 0.5 mL (1×106 cells) BMSCs were infused into the tail vein of rats of the cell transplantation group, and rats of other groups were treated with an equal volume of phosphate buffered saline. Main outcome measures: Changes in blood glucose concentration, triacylglycerol and insulin levels, pathological changes in renal tissues; distribution of cells in the kidney and pancreatic tissues. Results: Compared with pretransplantation, no significant difference in blood glucose concentration was detected in the model control group at 7, 14 and 21 days following transplantation, but the blood glucose concentration significantly decreased in the cell transplantation group (P < 0.001). At 21 days following transplantation, compared with the normal group, triacylglycerol levels significantly increased (P < 0.001), but insulin levels significantly reduced (P < 0.001) in the model control and cell transplantation groups. The reduction in insulin levels was lower in the cell transplantation group than in the model control group (P < 0.001). Staining for glycogen results showed that renal glomerulus became hypertrophy in the model control group; renal glomerulus matrix became thinner and hypertrophy was improved in the cell transplantation group. Insulin immunofluorence staining demonstrated that islet cells significantly reduced in the model control group; islet cells increased in the cell transplantation group; BrdU-positive cells were detected in the pancreas and kidney. Conclusion: The transplanted BMSCs can reside at the pancreatic site and renal of type 2 diabetic rats induced by tail vein injection, and can decrease blood glucose and increase insulin secretion.

[Changes in Bone Marrow Mesenchymal Stem Cells Osteogenesis by the Regulation of Lnk/stem Cell Factor-Ckit Signaling].

Bone Marrow Mesenchymal Stem Cells Ameliorated Kidney Fibrosis by Attenuating TLR4/NF-κB in Diabetic Rats.

Bone Marrow Mesenchymal Stem Cells Induce Angiogenesis and Attenuate the Remodeling of Diabetic Cardiomyopathy

Effect of DKK-1 gene scilence mediated by siRNA lentivirus vector on the differentiation of bone marrow mesenchymal stem cells

High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes in Rats Impacts Osteogenesis and Wnt Signaling in Bone Marrow Stromal Cells

miR-124-3p promotes BMSC osteogenesis via suppressing the GSK-3β/β-catenin signaling pathway in diabetic osteoporosis rats

SATB1 Promotes Osteogenic Differentiation of Diabetic Rat BMSCs Through MAPK Signalling Activation

[Expression of osteoclast differentiation factor and intercellular adhesion molecule-1 of bone marrow mesenchymal stem cells enhanced with osteogenic differentiation]

Effect of Liver Kinase B1 on Osteogenesis and Lipogenesis Differentiation of Bone Marrow Mesenchymal Stem Cells Under Oxidative Stress

The Role of Integrin-Linked Kinase in Regulating Bone Differentiation of Metabolic Syndrome-Derived Bone Marrow Mesenchymal Stem Cells Through Autophagy

Effect of the Abnormal Expression of BMP-4 in the Blood of Diabetic Patients on the Osteogenic Differentiation Potential of Alveolar BMSCs and the Rescue Effect of Metformin: A Bioinformatics-Based Study

Osteogenesis Ability of Bone Marrow-Derived Mesenchymal Stem Cells Derived from Diabetic Rabbits

Improvement of blood glucose and renal lesions in type 2 diabetic rats following bone marrow mesenchymal stem cell transplantation

Osteogenic Potential of Bone Marrow Stromal Cells Derived from Streptozotocin-Induced Diabetic Rats

Impacts of Bone Marrow Molecular Alterations on Endothelial Progenitor Cell Mobilization in Diabetic Mice

Roles of Wnt/β-Catenin Signaling in Retinal Neuron-Like Differentiation of Bone Marrow Mesenchymal Stem Cells from Nonobese Diabetic Mice

Bone Marrow Mesenchymal Stem Cell Therapy on Diabetic Nephropathy in Rats

Regulation Of Osteogenic Differentiation Of Bone Marrow Mesenchymal Stem Cells By Intermittent Hypoxia

Changes of alkaline phosphatase gene expression level in osteogenic differentiation of bone marrow mesenchymal stem cells

Rhpdgf-Bb Promotes Proliferation and Osteogenic Differentiation of Bone Marrow Stromal Cells from Streptozotocin-Induced Diabetic Rats Through ERK Pathway

Effect of Insulin on Bone Formation Ability of Rat Alveolar Bone Marrow Mesenchymal Stem Cells